A proposed Merck & Co medicine eliminated the liver-destroying hepatitis C virus although anemia and other safety concerns remained for the potential blockbuster pill, US drug reviewers said.
More than 100 cases of a potentially fatal brain infection have been reported among patients who took Biogen Idec's multiple sclerosis drug Tysabri, US health officials said on Friday.
Gulf Pharmaceutical Industries, known as Julphar, reported a 16 per cent increase in first- quarter profit to Dh52.8 million from the year-ago period, according to a statement to the Abu Dhabi bourse
Abbott Laboratories reported slightly better-than-expected quarterly earnings on strong sales of branded and generic medicines and medical devices.
The US health regulators approved Roche Holding AG's big selling arthritis and cancer drug Rituxan for treating two rare disorders that cause blood vessel inflammation.
Danish biotech company Genmab has struck a second cancer research agreement with Seattle Genetics, which will give it rights to use the US company's antibody technology.
Actelion Ltd, under pressure from its largest shareholder Elliott, reported first-quarter net income that beat forecasts as it sought to convince investors it has the right strategy.
Swiss drugmaker Novartis AG stuck to its 2011 outlook after posting better-than-expected first-quarter sales as demand for its products remained robust.
Biotech investment fund BB Biotech has come out in support of Actelion Ltd, giving the Swiss biotech group crucial backing in its spat with its largest shareholder Elliott Advisors.
Community Health Systems Inc was subpoenaed by the US government in connection with an investigation of possible improper claims submitted to Medicare and Medicaid, days after rival Tenet Healthcare C
